In this study, we evaluated the goldfish model of hemilabyrinthectomy for investigating potential recovery-promoting drugs. In this lesion model, the unilateral removal of the labyrinth induces a postural imbalance in response to light (Dorsal Light Reflex), from which the animals can recover over time. The behavioral effects of two neuropeptides were testednamely, of substance P and ACTH4-10, both of which are known to promote functional recovery in several other lesion models. Furthermore, the effect of MK-801, an antagonist of the glutamatergic NMDAreceptor subtype, was tested because this substance has also been shown to exert a neuroprotective effect. After lesion of the right labyrinth, the animals (n=12) were treated intraperitoneally daily either with vehicle (n=12), substance P (n=ll), 
INTRODUCTION
Hemilabyrinthectomy is a lesion model that has the important characteristic of lesioning the CNS without directly damaging tissue in the brain. The main behavioral consequence of this unilateral vestibular removal is a postural imbalance from which the animals can recover over time. Therefore, this model has been used in various species to study functional recovery and its possible physiological determinants (Schaefer & Meyer, 1974; Dieringer, 1995; Deliagina, 1997; Vidal et al., 1998) .
In goldfish, behavioral deficits and potential recovery after hemilabyrinthectomy can elegantly be studied by measuring the dorsal light reflex (DLR) (Ott & Platt, 1988a; 1988b) : When illuminated from one side, non-lesioned fish slightly tilt toward the light source, which indicates a role of vision in postural maintenance. Vestibular-lesioned fish, on the other hand, tilt very strongly toward the light, and some of them even align themselves fully with the light, indicating the loss of influence of the gravitational component on postural maintenance. With time after lesion, the degree of light-induced tilt can decrease, which is taken as the index of functional recovery. Apparently, after the loss of vestibular input, fish initially adjust posture, mainly using the visual system, whereas during the development of functional recovery, the impact of the gravitational component gradually increases again. Such recovery after hemilabyrinthectomy is thought to be due to compensatory mechanisms, including the following:
bilateral adjustments in the activity of vestibular nuclei (Flohr & Beinhold, 1981; Sans et al., 1997) , modulation of the lesion side via commissural interconnections (Dieringer & Precht, 1979) , cerebellar input to the vestibular neurons (Dieringer & Precht, 1979) , and neurochemical modulation via cholinergic systems (Beinhold & Flohr, 1980 (Schaefer & Meyer, 1974) to promote functional recovery after brain lesions (Mattioli et al., 1992; Bannon et al., 1995) and to act in a neurotrophic and neuroprotective way (Jonsson & Hallman, 1982; Iwasaki et al., 1989; Kowall et al., 1991; Mattioli et al., 1992; Nikolaus et al., 1999) . ACTH4-10 can also accelerate recovery after hemilabyrithectomy in frogs (Flohr & Liineburg, 1982) and monkeys (Igarashi et al.; 1985) and after lesions of the CNS (Antonawich et al., 1993;  for review see van Rijzingen et al., 1996 ). Furthermore, we tested the non-competitive NMDA receptor antagonist MK-801 (dizolcipine), for which a positive effect on recovery after brain lesions is disputed. It has been suggested that MK-801 might be able to act neuro-protectively (Grigg & Anderson, 1990; Robinson & Mair, 1992; Yanase et al., 1995) , an action that may be due to decreases of secondary mechanisms affecting neuronal death, especially edema (Yanase et al., 1995) and calcium channel blocking (Schurr et al., 1995) . Contradictory data exist, however, because Holtz & Gerdin (1991) (Fig. 1 ).
Drugs and treatmensts
Substance P acetate and ACTH4-10 (Sigma Chemical Co., St Louis, Missouri, USA); and MK-801 (RBI, Natick, Massachusetts, USA) were dissolved in distilled water to concentrations of 25 lag/mL (SP), 125 lxg/mL (ACTH4-10), and 50 tg/mL (MK-801). All substances were placed immediately in a freezer (-40C) in aliquots of 250 tL. Fresh aliquots were thawed on each injection day. All substances were administered in a volume of 2 mL/kg body weight using a 1-mL syringe and a 27-gage needle. The final doses used were 50 Mg/kg for SP, 250 gg/kg for ACTH4-10, and 100 lag/kg for MK-801. These doses were derived from previous studies (Flohr & Liineburg, 1982; Mattioli et al., 1995 Mattioli et al., , 1996 1997) (Ott & Platt, 1988a , 1988b 
RESULTS
After recovering from anesthesia, the labyrinthectomized animals showed immediate ataxia that lasted between 30 and 40 min; a few animals that did not recover from this ataxia were not used further in the study. On the first test, performed on the first day after surgery and before any treatment was administered, the lesion groups showed a body tilt toward the light side of about 50 degrees, whereas the no-lesion control group had a tilt of about 7 degrees to the same side. The degree of tilt was significantly higher in the lesion groups than in the no-lesion group (Table 1) .
Throughout the postoperative testing period, the statistical analysis of DRL (two-way ANOVA with repeated measures, Fig. 2 (1988a, 1988b) . Curiously, Ott and Platt reported substantially lower tilt angles 1-day post-hemilabyrinthectomy than those noted in this study (mean 19.2 versus 48.6). The reason for this difference is not clear but is presumably due to some methodological differences between the two studies (namely, light levels in the test apparatus) and warrants further study.
The results with the three drug treatments in this study indicate that not only the neuropeptides SP and ACTH4-10 but also the NMDA receptor blocker MK-801 accelerated functional recovery of body tilt induced by DLR in the goldfish model of hemilabyrinthectomy. The absence of rebound increase in body tilt on the tests performed after the termination of drug treatments indicates that the postural improvement was not due to a temporary drug effect but may have occurred through a process of reorganization.
The two neuropeptides tested, that is, SP and ACTH4-10, have previously been shown to improve functional recovery in different lesion models and species (Flohr & Ltineburg, 1982; Igarashi et al., 1985; Mattioli et al., 1992; Antonawich et al., 1993; Bannon et al., 1995; Sprick et al., 1996) . Such promotive effects might be due to their known neurotrophic effects (Jonsson & Hallman, 1982; Nyakas et al., 1985; van der Neut et al., 1988; Iwasaki et al., 1989; Kowall et al., 1991) . Nevertheless, neuronal regeneration usually takes weeks to months to occur (Antonawich et al., 1993; Zottoli et al., 1994;  for review see Marshall, 1985) ; therefore, such a mechanism is rather unlikely to have been critical in the present experiment because the peptidergic treatments led to functional recovery within days. Alternatively, they may have acted neurochemically by inducing short term changes that compensated for the lesion-induced loss; in this case, however, cessation of drug treatment should have led to a reappearence of deficits (Flohr & Ltineburg, 1982) , which did not occur, at least during the subsequent 4 days.
Because functional recovery after lesion is also dependent on the organism's ability to relearn or to compensate behaviorally (Morgan et al., 1983; Mattioli et al., 1988) , the role of learning and behavioral compensation must be considered as altemative or additive factors. Both SP and ACTH have been shown to promote learning and memory (Greven & de Wied, 1973; de Wied & Gispen, 1977; Stiubli & Huston, 1980; Wetzel & Matthies, 1982; Tomaz & Huston, 1986; Tomaz et al., 1990; Wan et al., 1992; Huston & Hasen6hrl, 1995; Mattioli et al., 1997) , and to have reinforcing effects in rats and goldfish (Huston & Oitzl, 1989; Oitzl et al., 1990; Huston & Hasen6hrl, 1995; Mattioli et al., 1995; , and such effects may facilitate functional recovery, for example, by improving behavioral compensation and re-learning. Effects on learning might also explain why the peptides acted rather rapidly and why their effectiveness outlasted drug discontinuation.
From such a learning hypothesis, one should have expected that the NMDA receptor antagonist should not promote recovery because this drug is known to impair learning and memory in several paradigms (Xu & Davies, 1992; Buffalo et al., 1994; Caramanos & Shapiro, 1994; Davis & Klinger, 1994; Paule, 1994; Filliat & Blanchet, 1995; Hudzik & Palmer, 1995; Kesner & Dakis, 1995; Mele et alo, 1995; Ylinen et al., 1995; Verma & Moghaddam, 1996) . Our results, however, indicate that MK-801 actually improves functional recovery. Apparently, the drug's action on recovery is dependent on a mechanism other than learning. Possibly, MK-801 acted neuroprotectively (Grigg & Anderson, 1990; Robinson & Mair, 1992; Yanase et al., 1995 (Flohr & Ltineburg, 1993) , in which MK-801 treatment resulted in an inhibition of the initial phases of recovery in goldfish and frogs. Such different results might reflect important dose dependencies because the former authors administered comparatively high dosages, that is, 0.5 and 2.0 mg/kg, whereas we used 100 lag/kg. Furthermore, it might be possible that even a low dose of MK-801 might disturb behavioral compensation acutely after injection (Kim et al., 1997) , whereas such an effect is no longer present after 24 h, the timepoint at which we measured the animal's behavior.
In a recent review (de Waele, 1995) , the complex neurochemistry of the vestibular system was summarized. In addition to SP, ACTH, and glutamate, this system has neurons containing somatostatin, enkephaline, GABA, glycine, acetylcholine, noradrenaline, dopamine, serotonine, and histamine; more than 21 receptor types are present. Examining the full range of agonists and antagonists of these receptors on functional recovery is still an incomplete task. The model used in the present study is one of the tools that can help to dissect the vestibular system pharmacologically, as well as, the functional recovery processes after vestibular lesions.
In 
